High-risk histopathological features of retinoblastoma following primary enucleation: A Global Study Of 1,426 Patients From 5 Continents
Descripción del Articulo
Purpose: To evaluate high-risk histopathological features following primary enucleation of eyes with retinoblastoma and assess the patient outcomes across continents. Methods: A retrospective study of 1,426 primarily enucleated retinoblastoma eyes from five continents. Results: Of all, 923 (65%) wer...
| Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | artículo |
| Fecha de Publicación: | 2024 |
| Institución: | Instituto Nacional de Enfermedades Neoplásicas |
| Repositorio: | INEN-Institucional |
| Lenguaje: | inglés |
| OAI Identifier: | oai:repositorio.inen.sld.pe:20.500.14703/432 |
| Enlace del recurso: | https://hdl.handle.net/20.500.14703/432 |
| Nivel de acceso: | acceso abierto |
| Materia: | chemotherapy enucleation eye high-risk features histopathology retinoblastoma tumor https://purl.org/pe-repo/ocde/ford#3.02.21 |
| id |
INEN_71c9f848b9dfdef51886926fdda53374 |
|---|---|
| oai_identifier_str |
oai:repositorio.inen.sld.pe:20.500.14703/432 |
| network_acronym_str |
INEN |
| network_name_str |
INEN-Institucional |
| repository_id_str |
. |
| dc.title.none.fl_str_mv |
High-risk histopathological features of retinoblastoma following primary enucleation: A Global Study Of 1,426 Patients From 5 Continents |
| title |
High-risk histopathological features of retinoblastoma following primary enucleation: A Global Study Of 1,426 Patients From 5 Continents |
| spellingShingle |
High-risk histopathological features of retinoblastoma following primary enucleation: A Global Study Of 1,426 Patients From 5 Continents Kaliki, S chemotherapy enucleation eye high-risk features histopathology retinoblastoma tumor https://purl.org/pe-repo/ocde/ford#3.02.21 |
| title_short |
High-risk histopathological features of retinoblastoma following primary enucleation: A Global Study Of 1,426 Patients From 5 Continents |
| title_full |
High-risk histopathological features of retinoblastoma following primary enucleation: A Global Study Of 1,426 Patients From 5 Continents |
| title_fullStr |
High-risk histopathological features of retinoblastoma following primary enucleation: A Global Study Of 1,426 Patients From 5 Continents |
| title_full_unstemmed |
High-risk histopathological features of retinoblastoma following primary enucleation: A Global Study Of 1,426 Patients From 5 Continents |
| title_sort |
High-risk histopathological features of retinoblastoma following primary enucleation: A Global Study Of 1,426 Patients From 5 Continents |
| author |
Kaliki, S |
| author_facet |
Kaliki, S Vempuluru, VS Bakal, KR Dorji, S Tanna, V Shields, CN Fallon, SJ Raval, V Ahmad, A Mushtaq, A Hussain, M Yousef, YA Mohammad, M Roy, SR Huque, F Tatiana, U Yuri, S Vladimir, P Zambrano, SC Alarcón-León, S Valdiviezo-Zapata, C Vargas-Martorellet, M Gutierrez-Chira, C Buitrago, M Ortiz, JS Diaz-Coronado, R Tripathy, D Rath, S Patil, G Berry, JL Pike, S Brown, B Tanabe, M Frenkel, S Eiger-Moscovich, M Pe'er, J Shields, CL Eagle, RC,, Jr Laiton, A Velasco, AM Vega, K Desimone, J Bejjanki, KM Kapoor, AG Venkataraman, A Bryant, V Reddy, MA Sagoo, MS Hubbard, GB Azarcon, CP Olson, TA Grossniklaus, H Rolfe, O Staffieri, SE O'day, R Mathew, AA Elder, JE Mckenzie, JD Fabian, ID Shemesh, R Vishnevskia-Dai, V Ali, MH Jakati, S Mishra, DK Palkonda, VAR |
| author_role |
author |
| author2 |
Vempuluru, VS Bakal, KR Dorji, S Tanna, V Shields, CN Fallon, SJ Raval, V Ahmad, A Mushtaq, A Hussain, M Yousef, YA Mohammad, M Roy, SR Huque, F Tatiana, U Yuri, S Vladimir, P Zambrano, SC Alarcón-León, S Valdiviezo-Zapata, C Vargas-Martorellet, M Gutierrez-Chira, C Buitrago, M Ortiz, JS Diaz-Coronado, R Tripathy, D Rath, S Patil, G Berry, JL Pike, S Brown, B Tanabe, M Frenkel, S Eiger-Moscovich, M Pe'er, J Shields, CL Eagle, RC,, Jr Laiton, A Velasco, AM Vega, K Desimone, J Bejjanki, KM Kapoor, AG Venkataraman, A Bryant, V Reddy, MA Sagoo, MS Hubbard, GB Azarcon, CP Olson, TA Grossniklaus, H Rolfe, O Staffieri, SE O'day, R Mathew, AA Elder, JE Mckenzie, JD Fabian, ID Shemesh, R Vishnevskia-Dai, V Ali, MH Jakati, S Mishra, DK Palkonda, VAR |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
| dc.contributor.author.fl_str_mv |
Kaliki, S Vempuluru, VS Bakal, KR Dorji, S Tanna, V Shields, CN Fallon, SJ Raval, V Ahmad, A Mushtaq, A Hussain, M Yousef, YA Mohammad, M Roy, SR Huque, F Tatiana, U Yuri, S Vladimir, P Zambrano, SC Alarcón-León, S Valdiviezo-Zapata, C Vargas-Martorellet, M Gutierrez-Chira, C Buitrago, M Ortiz, JS Diaz-Coronado, R Tripathy, D Rath, S Patil, G Berry, JL Pike, S Brown, B Tanabe, M Frenkel, S Eiger-Moscovich, M Pe'er, J Shields, CL Eagle, RC,, Jr Laiton, A Velasco, AM Vega, K Desimone, J Bejjanki, KM Kapoor, AG Venkataraman, A Bryant, V Reddy, MA Sagoo, MS Hubbard, GB Azarcon, CP Olson, TA Grossniklaus, H Rolfe, O Staffieri, SE O'day, R Mathew, AA Elder, JE Mckenzie, JD Fabian, ID Shemesh, R Vishnevskia-Dai, V Ali, MH Jakati, S Mishra, DK Palkonda, VAR |
| dc.subject.none.fl_str_mv |
chemotherapy enucleation eye high-risk features histopathology retinoblastoma tumor |
| topic |
chemotherapy enucleation eye high-risk features histopathology retinoblastoma tumor https://purl.org/pe-repo/ocde/ford#3.02.21 |
| dc.subject.ocde.none.fl_str_mv |
https://purl.org/pe-repo/ocde/ford#3.02.21 |
| description |
Purpose: To evaluate high-risk histopathological features following primary enucleation of eyes with retinoblastoma and assess the patient outcomes across continents. Methods: A retrospective study of 1,426 primarily enucleated retinoblastoma eyes from five continents. Results: Of all, 923 (65%) were from Asia (AS), 27 (2%) from Australia (AUS), 120 (8%) from Europe (EUR), 162 (11%) from North America (NA), and 194 (14%) from South America (SA). Based on the continent (AS vs. AUS vs. EUR vs. NA vs. SA), the histopathological features included massive choroidal invasion (31% vs. 7% vs. 13% vs. 19% vs. 27%, P = 0.001), postlaminar optic nerve invasion (27% vs. 0% vs. 16% vs. 21% vs. 19%, P = 0.0006), scleral infiltration (5% vs. 0% vs. 4% vs. 2% vs. 7%, P = 0.13), and microscopic extrascleral infiltration (4% vs. 0% vs. <1% vs. <1% vs. 4%, P = 0.68). Adjuvant chemotherapy with/without orbital radiotherapy was given to 761 (53%) patients. Based on Kaplan-Meier estimates in different continents (AS vs. AUS vs. EUR vs. NA vs. SA), the 6-year risk of orbital tumor recurrence was 5% versus 2% versus 0% versus 0% versus 12% (P < 0.001), systemic metastasis was reported in 8% versus 5% versus 2% versus 0% versus 13% (P = 0.001), and death in 10% versus 3% versus 2% versus 0% versus 11% (P < 0.001) patients. Conclusion: There is a wide variation in the infiltrative histopathological features of retinoblastoma across continents, resulting in variable outcomes. SA and AS had a higher risk of orbital tumor recurrence, systemic metastasis, and death compared to AUS, EUR, and NA. Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. |
| publishDate |
2024 |
| dc.date.accessioned.none.fl_str_mv |
2025-02-05T17:30:14Z |
| dc.date.available.none.fl_str_mv |
2025-02-05T17:30:14Z |
| dc.date.issued.fl_str_mv |
2024 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article |
| dc.type.version.none.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.doi.none.fl_str_mv |
10.1097/IAE.0000000000004250 |
| dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/20.500.14703/432 |
| dc.identifier.journal.none.fl_str_mv |
Retina |
| identifier_str_mv |
10.1097/IAE.0000000000004250 Retina |
| url |
https://hdl.handle.net/20.500.14703/432 |
| dc.language.iso.none.fl_str_mv |
eng |
| language |
eng |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| dc.rights.uri.none.fl_str_mv |
https://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0/ |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Lippincott Williams and Wilkins |
| dc.publisher.country.none.fl_str_mv |
US |
| publisher.none.fl_str_mv |
Lippincott Williams and Wilkins |
| dc.source.none.fl_str_mv |
reponame:INEN-Institucional instname:Instituto Nacional de Enfermedades Neoplásicas instacron:INEN |
| instname_str |
Instituto Nacional de Enfermedades Neoplásicas |
| instacron_str |
INEN |
| institution |
INEN |
| reponame_str |
INEN-Institucional |
| collection |
INEN-Institucional |
| bitstream.url.fl_str_mv |
https://repositorio.inen.sld.pe/backend/api/core/bitstreams/d926f075-b433-4a05-8d5a-db5417698a91/download https://repositorio.inen.sld.pe/backend/api/core/bitstreams/67ebd0d5-8e4b-4736-9906-db46a3b868cf/download https://repositorio.inen.sld.pe/backend/api/core/bitstreams/757cfa74-d4db-4e4d-9e64-a779e2ab2afe/download |
| bitstream.checksum.fl_str_mv |
30cb438bc6678aca3a14ce335a9093ec fc91026246c6589b5b085515c6ab664f 02d48dfdefae557def8a717bca5c9c6d |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositorio del Instituto Nacional de Enfermedades Neoplásicas |
| repository.mail.fl_str_mv |
repositorio@inen.sld.pe |
| _version_ |
1868438555594850304 |
| spelling |
PublicationKaliki, SVempuluru, VSBakal, KRDorji, STanna, VShields, CNFallon, SJRaval, VAhmad, AMushtaq, AHussain, MYousef, YAMohammad, MRoy, SRHuque, FTatiana, UYuri, SVladimir, PZambrano, SCAlarcón-León, SValdiviezo-Zapata, CVargas-Martorellet, MGutierrez-Chira, CBuitrago, MOrtiz, JSDiaz-Coronado, RTripathy, DRath, SPatil, GBerry, JLPike, SBrown, BTanabe, MFrenkel, SEiger-Moscovich, MPe'er, JShields, CLEagle, RC,, JrLaiton, AVelasco, AMVega, KDesimone, JBejjanki, KMKapoor, AGVenkataraman, ABryant, VReddy, MASagoo, MSHubbard, GBAzarcon, CPOlson, TAGrossniklaus, HRolfe, OStaffieri, SEO'day, RMathew, AAElder, JEMckenzie, JDFabian, IDShemesh, RVishnevskia-Dai, VAli, MHJakati, SMishra, DKPalkonda, VAR2025-02-05T17:30:14Z2025-02-05T17:30:14Z202410.1097/IAE.0000000000004250https://hdl.handle.net/20.500.14703/432RetinaPurpose: To evaluate high-risk histopathological features following primary enucleation of eyes with retinoblastoma and assess the patient outcomes across continents. Methods: A retrospective study of 1,426 primarily enucleated retinoblastoma eyes from five continents. Results: Of all, 923 (65%) were from Asia (AS), 27 (2%) from Australia (AUS), 120 (8%) from Europe (EUR), 162 (11%) from North America (NA), and 194 (14%) from South America (SA). Based on the continent (AS vs. AUS vs. EUR vs. NA vs. SA), the histopathological features included massive choroidal invasion (31% vs. 7% vs. 13% vs. 19% vs. 27%, P = 0.001), postlaminar optic nerve invasion (27% vs. 0% vs. 16% vs. 21% vs. 19%, P = 0.0006), scleral infiltration (5% vs. 0% vs. 4% vs. 2% vs. 7%, P = 0.13), and microscopic extrascleral infiltration (4% vs. 0% vs. <1% vs. <1% vs. 4%, P = 0.68). Adjuvant chemotherapy with/without orbital radiotherapy was given to 761 (53%) patients. Based on Kaplan-Meier estimates in different continents (AS vs. AUS vs. EUR vs. NA vs. SA), the 6-year risk of orbital tumor recurrence was 5% versus 2% versus 0% versus 0% versus 12% (P < 0.001), systemic metastasis was reported in 8% versus 5% versus 2% versus 0% versus 13% (P = 0.001), and death in 10% versus 3% versus 2% versus 0% versus 11% (P < 0.001) patients. Conclusion: There is a wide variation in the infiltrative histopathological features of retinoblastoma across continents, resulting in variable outcomes. SA and AS had a higher risk of orbital tumor recurrence, systemic metastasis, and death compared to AUS, EUR, and NA. Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.application/pdfengLippincott Williams and WilkinsUSinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/4.0/chemotherapyenucleationeyehigh-risk featureshistopathologyretinoblastomatumorhttps://purl.org/pe-repo/ocde/ford#3.02.21High-risk histopathological features of retinoblastoma following primary enucleation: A Global Study Of 1,426 Patients From 5 Continentsinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionreponame:INEN-Institucionalinstname:Instituto Nacional de Enfermedades Neoplásicasinstacron:INENORIGINALretina-44-2105.pdfapplication/pdf233118https://repositorio.inen.sld.pe/backend/api/core/bitstreams/d926f075-b433-4a05-8d5a-db5417698a91/download30cb438bc6678aca3a14ce335a9093ecMD51trueAnonymousREADTEXTretina-44-2105.pdf.txtWritten by FormatFilter org.dspace.app.mediafilter.TikaTextExtractionFilter on 2025-05-09T08:00:45Z (GMT).Extracted texttext/plain52928https://repositorio.inen.sld.pe/backend/api/core/bitstreams/67ebd0d5-8e4b-4736-9906-db46a3b868cf/downloadfc91026246c6589b5b085515c6ab664fMD52falseAnonymousREADTHUMBNAILretina-44-2105.pdf.jpgWritten by FormatFilter org.dspace.app.mediafilter.PDFBoxThumbnail on 2025-05-09T08:00:46Z (GMT).Generated Thumbnailimage/jpeg45834https://repositorio.inen.sld.pe/backend/api/core/bitstreams/757cfa74-d4db-4e4d-9e64-a779e2ab2afe/download02d48dfdefae557def8a717bca5c9c6dMD53falseAnonymousREAD20.500.14703/432oai:repositorio.inen.sld.pe:20.500.14703/4322026-02-15T16:53:39.304Zhttps://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessopen.accesshttps://repositorio.inen.sld.peRepositorio del Instituto Nacional de Enfermedades Neoplásicasrepositorio@inen.sld.pe |
| score |
12.821158 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).